The advent of functional imaging has revolutionised our capacity to understand both normal and abnormal brain function. Of the currently available techniques, positron emission tomography (PET) is the most informative because it allows accurate quantification of cerebral blood flow and metabolism and superior spatial resolution. As a direct consequence of the introduction of PET methodology a decade ago, significant advances have been made in our knowledge of conditions which have a recognised neuropathology. These include degenerative brain disease, cerebrovascular disease, movement disorders and epilepsy. Such studies have yielded important findings which are not only academically interesting but also clinically relevant.' Perhaps the next great challenge for PET is the unravelling of the various neurobiological determinants of the so-called functional psychoses, schizophrenia and affective illness, since these are being increasingly recognised as having a substantial organic component. The early PET studies of these two conditions have provided some useful pointers towards the fundamental neuronal disturbances, but often the results from various PET centres have been inconsistent. For example some studies have found reduced activity in the frontal cortex of both depressed and schizophrenic patients whereas others have failed to replicate this finding. [2] [3] [4] There 27 This therefore supports Frith's hypothesis" that the negative features of schizophrenia are secondary to the inability to generate willed actions. Reality distortion was associated with increased activity in the left parahippocampal gyrus and can thus be related to Frith's hypothesis that positive schizophrenic phenomena are due to impaired monitoring of willed acts, a process localised to the left hippocampus. The frontal abnormality of CBF associated with the disorganisation syndrome was reduced activity in the right ventral prefrontal cortex and increased activity in the right anterior cingulate cortex. Although the neural basis of thought disorder has not been addressed by Frith, Liddle has found that this syndrome is associated with the inability to suppress inappropriate responses.26 Compatible with Liddle's findings, is the observation that lesions of the ventral prefrontal cortex in primates produce behavioural disinhibition. 28 Liddle has suggested that the activation of the anterior cingulate cortex in patients with the disorganisation syndrome represents the ineffective struggle to suppress inappropriate mental activity. An alternative interpretation, with respect to the theory of anterior cingulate function described above, is that motivational significance is being wrongly ascribed to irrelevant stimuli in patients with thought disorder.
Arguably, certain features of depression may represent an impairment in the generation of willed acts. These are generally considered under the rubric of psychomotor retardation and include subjective feelings of loss of energy and objective signs of slowness and apathy. Dolan reported a study of depression in which 40 patients and 40 matched normal volunteers had resting CBF scans.2930 The depressed group as a whole demonstrated reduced frontal activity in the left anterior cingulate cortex and left dorsolateral prefrontal cortex. Correlational analysis revealed that psychomotor retardation was related to decreased CBF in the dorsolateral prefrontal cortex. Thus in depression as well as schizophrenia an impairment of the initiation of voluntary behaviour is found in association with decreased function of the dorsolateral prefrontal cortex, supporting the notion that this finding is due to failure of a fundamental psychological function rather than an attribute of a specific disease process.
Although there are many issues that remain to be examined, the findings of distinct associations between mental phenomena, cognitive acts and regional brain abnormalities is remarkable. We can therefore look forward to a decade in which the growing body of knowledge concerning the genetic, neurochemical and neuropathological basis of various psychiatric disorders will be related to abnormal psychological function using PET.
Although this article has concentrated on the implications of advances in PET for psychiatric research a second method of functional imaging which is as yet in its infancy should be briefly mentioned. This is proton spectroscopy using MRI. Gadian described at the British Neuropsychiaty Association's Winter Meeting how MRI provides a noninvasive method of studying brain metabolism in vivo. He pointed out that although initial MRI studies investigated energy metabolism by examining 31p signals generated from ATP, phosphocreatine and inorganic phosphate moieties, the newly developed 'H spectroscopy may be of more interest. It offers better spatial resolution than the 31P technique and it can measure proton signals from neurophysiologically important chemicals such as N-acetylaspartate (NAA) and glutamate. For example, NAA is found almost exclusively in neurons and therefore is a putative marker of neuronal loss or damage. Glutamate, an excitatory neurotransmitter, has been implicated as a neurotoxic agent in various disorders including schizophrenia.3' It is likely that MRI spectroscopy will be a complementary rather than an alternative technique to PET. PET is able to detect dysfunctional brain areas but cannot distinguish, whether these are secondary to a cellular abnormality in the areas directly under inspection or the effects of remote lesions disrupting the integrity of projection systems to the site of the detected abnormalities. Furthermore, a recent structural MRI study reported by Ron,32 has demonstrated that schizophrenic patients have reduced global cerebral volume, a finding seemingly at odds with the PET data which suggests that the functional abnormalities are localised to specific brain areas. The presence of global brain atrophy does not imply global brain dysfunction. MRI spectroscopy has the ability to detect the consequences of neuronal damage for cellular metabolism in various regions and may provide a bridge between findings derived from MRI structural imaging and PET fumctional imaging of the brain in schizophrenia and other psychiatric disorders.
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